The IBD and PSC Phenotypes of PSC-IBD
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,General Medicine
Link
http://link.springer.com/article/10.1007/s11894-018-0620-2/fulltext.html
Reference105 articles.
1. Karlsen TH, Folseraas T, Thorburn D, Vesterhus M. Primary sclerosing cholangitis—a comprehensive review. J Hepatol. 2017;67(6):1298–323. https://doi.org/10.1016/j.jhep.2017.07.022 .
2. Saffioti F, Gurusamy KS, Hawkins N, Toon CD, Tsochatzis E, Davidson BR, et al. Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis. Cochrane Database Syst Rev. 2017;3:Cd011343. https://doi.org/10.1002/14651858.CD011343.pub2 .
3. Peng X, Luo X, Hou JY, Wu SY, Li LZ, Zheng MH, et al. Immunosuppressive agents for the treatment of primary sclerosing cholangitis: a systematic review and meta-analysis. Dig Dis (Basel, Switzerland). 2017;35(5):478–85. https://doi.org/10.1159/000471874 .
4. Lazaridis KN, LaRusso NF. Primary sclerosing cholangitis. N Engl J Med. 2016;375(12):1161–70. https://doi.org/10.1056/NEJMra1506330 .
5. Weersma RK, Lindor KD. Shifting paradigms: what is the true prevalence and clinical course of primary sclerosing cholangitis? Gastroenterology. 2016;151(4):590–3. https://doi.org/10.1053/j.gastro.2016.08.046 .
Cited by 65 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. It’s Not Always Infections When It Comes to Resource-Poor Countries: A Fascinating Case Report;Cureus;2024-08-08
2. Good long-term outcomes of primary sclerosing cholangitis in childhood;JHEP Reports;2024-08
3. Liver enzyme profiles after initiating biological treatment in children with inflammatory bowel diseases;Journal of Pediatric Gastroenterology and Nutrition;2024-07
4. The Swedish initiative for the study of Primary sclerosing cholangitis (SUPRIM);eClinicalMedicine;2024-04
5. Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis‐associated inflammatory bowel disease (PSC‐IBD): A matched analysis from the Paediatric PSC Consortium;Alimentary Pharmacology & Therapeutics;2024-03-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3